Pancreatic Cancer Research

ResearcherCancer Center AmsterdamNo recent work listed

Hendrik A. Marsman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4476-147X; OpenAlex author ID A5003578868. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. Added value of 3T MRI and the MRI-halo sign in assessing resectability of locally advanced pancreatic cancer following induction chemotherapy (IMAGE-MRI): pros… Co-author DOI 10.1007/s00423-022-02653-y↗
  2. Added value of CA19-9 response in predicting resectability of locally advanced pancreatic cancer following induction chemotherapy. Co-author DOI 10.1016/j.hpb.2018.01.001↗
  3. [New developments in the treatment of pancreatic cancer]. Co-author PMID 27758723↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marc G. Besselink · 3 shared papers, 2016–2022 · strength 0.33
  2. Krijn P. van Lienden · 2 shared papers, 2018–2022 · strength 0.20
  3. Johanna W. Wilmink · 2 shared papers, 2018–2022 · strength 0.20
  4. Eran van Veldhuisen · 2 shared papers, 2018–2022 · strength 0.20
  5. Hanneke W.M. van Laarhoven · 2 shared papers, 2018–2022 · strength 0.20
  6. L. Bengt van Rijssen · 1 shared paper, 2022 · strength 0.12
  7. Remy Klaassen · 1 shared paper, 2022 · strength 0.12
  8. Leonard W. F. Seelen · 1 shared paper, 2022 · strength 0.12
  9. Aart Johannes Nederveen · 1 shared paper, 2022 · strength 0.12
  10. Oliver J. Gurney‐Champion · 1 shared paper, 2022 · strength 0.12
  11. Thomas F. Stoop · 1 shared paper, 2022 · strength 0.12
  12. Ignace H. J. T. de Hingh · 1 shared paper, 2022 · strength 0.12
  13. Sjors Klompmaker · 1 shared paper, 2018 · strength 0.08
  14. Jantien A. Vogel · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.